This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Selective Serotonin Reuptake Inhibitor

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Selective Serotonin Reuptake Inhibitors (SSRIs) Are

Selective serotonin reuptake inhibitors, often called SSRIs, are medicines used to help improve mood and relieve symptoms of depression and anxiety. They work by increasing the levels of serotonin, a chemical messenger in the brain that helps regulate mood, emotions, appetite, and sleep. SSRIs prevent the brain from reabsorbing serotonin too quickly, leaving more available to support emotional balance.

Common SSRIs include drugs such as citalopram (also known by the brand name Celexa), escitalopram, fluoxetine, paroxetine, and sertraline. These medications are widely prescribed and are considered a first-line treatment for moderate to severe depression and certain anxiety disorders.

Why SSRIs Matter in Cancer Care

Receiving a cancer diagnosis and undergoing treatment can be emotionally challenging. Many people with cancer experience feelings of sadness, anxiety, or depression. SSRIs may be prescribed as part of supportive care to help manage these emotional symptoms and improve quality of life. While SSRIs do not treat cancer itself, addressing mental health is an important part of overall cancer care and recovery.

Doctors may recommend SSRIs to help patients cope with the stress and emotional impact of cancer diagnosis, treatment side effects, or changes in daily life. These medications can support mood and reduce anxiety, helping patients feel more balanced during difficult times.

What Patients Might See or Hear About SSRIs

You might hear your healthcare team mention SSRIs during discussions about managing mood changes or emotional distress. SSRIs may appear in your medication list, treatment plan, or supportive care notes. Sometimes, the brand name of a drug like Celexa (citalopram) is used instead of the term SSRI, which can be confusing. Both names refer to the same type of medication.

Being prescribed an SSRI does not mean your cancer is worsening or that you have a mental health diagnosis beyond what your doctor has explained. Instead, it is a tool to help manage feelings that many people experience during cancer treatment and recovery.

Common Questions to Ask Your Care Team

If an SSRI is recommended for you, it can be helpful to ask why it is being prescribed, what side effects to watch for, how long you might need to take it, and how you will know if it is working. Discuss any concerns or symptoms you experience while taking the medication. Open communication with your healthcare team can help ensure you receive the best support.

Understanding SSRIs in Context

SSRIs are one type of antidepressant medication. Other types include tricyclic antidepressants and newer drugs with different effects. SSRIs are often preferred because they tend to have fewer side effects and are generally well tolerated. However, like all medications, SSRIs can cause side effects and may interact with other drugs, so they should only be taken as prescribed and under medical supervision.

It is important to remember that seeing the term SSRI or the name of an SSRI medication in your medical records or treatment plan is educational and does not automatically mean you will take these medicines or that you have depression. These medications may also be used for other symptoms such as anxiety, certain types of pain, or sleep difficulties.

Next Steps and Safety

This information is meant to help you understand what SSRIs are and how they might be used in cancer care. It does not replace personalized medical advice. If you have questions or concerns about SSRIs or your emotional health, talk openly with your healthcare team. They can explain how these medications fit into your overall care and help you feel more supported during your cancer journey.

Sources

Public source information used for this glossary entry includes: